Talwar R, Jagath J R, Rao N A, Savithri H S
Department of Biochemistry, Indian Institute of Science, Bangalore, India.
Eur J Biochem. 2000 Mar;267(5):1441-6. doi: 10.1046/j.1432-1327.2000.01142.x.
The three-dimensional structures of rabbit and human liver cytosolic serine hydroxymethyltransferase revealed that H231 interacts with the O3' of pyridoxal-5'-phosphate and other residues at the active site such as S203, K257, H357 and R402 (numbering as per the human enzyme). This and the conserved nature of H231 in all serine hydroxymethyltransferases highlights its importance in catalysis and/or maintenance of oligomeric structure of the enzyme. In an attempt to decipher the role of H230 (H231 of the human enzyme) in the catalytic mechanism and/or maintenance of oligomeric structure of sheep liver serine hydroxymethyltransferase, the residue was mutated to arginine, phenylalanine, alanine, asparagine or tyrosine. Our results suggest that the nature of the amino acid substitution has a marked effect on the catalytic activity of the enzyme. H230R and H230F mutant proteins were completely inactive, dimeric and did not bind pyridoxal-5'-phosphate. On the other hand, mutation to alanine and asparagine retained the oligomeric structure and ability to bind pyridoxal-5'-phosphate. These mutants had only 2-3% catalytic activity. The side reactions like transamination and 5,6,7, 8-tetrahydrofolate independent aldol cleavage were much more severely affected. They were able to form the external aldimine with glycine and serine but the quinonoid intermediate was not observed upon the addition of 5,6,7,8-tetrahydrofolate. Mutation to tyrosine did not affect the oligomeric structure and pyridoxal-5'-phosphate binding. The H230Y enzyme was 10% active and showed a correspondingly lower amount of quinonoid intermediate. The kcat / Km values for L-serine and Lallothreonine were 10-fold and 174-fold less for this mutant enzyme compared to the wild-type protein. These results suggest that H230 is involved in the step prior to the formation of the quinonoid intermediate, possibly in orienting the pyridine ring of the cofactor, in order to facilitate effective proton abstraction.
兔和人肝脏胞质丝氨酸羟甲基转移酶的三维结构显示,H231(按照人源酶编号)与磷酸吡哆醛的O3'以及活性位点的其他残基如S203、K257、H357和R402相互作用。H231在所有丝氨酸羟甲基转移酶中的保守性质突出了其在催化和/或维持酶的寡聚结构方面的重要性。为了阐明H230(人源酶中的H231)在绵羊肝脏丝氨酸羟甲基转移酶催化机制和/或维持寡聚结构中的作用,该残基被突变为精氨酸、苯丙氨酸、丙氨酸、天冬酰胺或酪氨酸。我们的结果表明,氨基酸取代的性质对酶的催化活性有显著影响。H230R和H230F突变蛋白完全无活性,呈二聚体形式,且不结合磷酸吡哆醛。另一方面,突变为丙氨酸和天冬酰胺保留了寡聚结构和结合磷酸吡哆醛的能力。这些突变体仅具有2 - 3%的催化活性。转氨作用和5,6,7,8 - 四氢叶酸非依赖性醛醇裂解等副反应受到的影响更为严重。它们能够与甘氨酸和丝氨酸形成外部醛亚胺,但加入5,6,7,8 - 四氢叶酸后未观察到醌型中间体。突变为酪氨酸不影响寡聚结构和磷酸吡哆醛结合。H230Y酶具有10%的活性,相应地醌型中间体的量较低。与野生型蛋白相比,该突变酶对L - 丝氨酸和L - 别苏氨酸的kcat / Km值分别低10倍和174倍。这些结果表明,H230参与醌型中间体形成之前的步骤,可能是为了促进辅因子吡啶环的定向,以便有效地夺取质子。